Index
1 Market Overview of Intravenous(IV) Therapy and Vein Access
1.1 Intravenous(IV) Therapy and Vein Access Market Overview
1.1.1 Intravenous(IV) Therapy and Vein Access Product Scope
1.1.2 Intravenous(IV) Therapy and Vein Access Market Status and Outlook
1.2 Global Intravenous(IV) Therapy and Vein Access Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Intravenous(IV) Therapy and Vein Access Market Size by Region (2018-2029)
1.4 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Region (2018-2023)
1.5 Global Intravenous(IV) Therapy and Vein Access Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Intravenous(IV) Therapy and Vein Access Market Size (2018-2029)
1.6.1 North America Intravenous(IV) Therapy and Vein Access Market Size (2018-2029)
1.6.2 Europe Intravenous(IV) Therapy and Vein Access Market Size (2018-2029)
1.6.3 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size (2018-2029)
1.6.4 Latin America Intravenous(IV) Therapy and Vein Access Market Size (2018-2029)
1.6.5 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size (2018-2029)
2 Intravenous(IV) Therapy and Vein Access Market by Type
2.1 Introduction
2.1.1 Infusion Pumps
2.1.2 Implantable Ports
2.1.3 Intravenous Catheters
2.1.4 Hypodermic Needles
2.1.5 Other
2.2 Global Intravenous(IV) Therapy and Vein Access Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Type (2018-2023)
2.2.2 Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Type (2018-2029)
3 Intravenous(IV) Therapy and Vein Access Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinics
3.1.3 Other
3.2 Global Intravenous(IV) Therapy and Vein Access Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Intravenous(IV) Therapy and Vein Access Historic Market Size by Application (2018-2023)
3.2.2 Global Intravenous(IV) Therapy and Vein Access Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Intravenous(IV) Therapy and Vein Access Revenue Breakdown by Application (2018-2029)
4 Intravenous(IV) Therapy and Vein Access Competition Analysis by Players
4.1 Global Intravenous(IV) Therapy and Vein Access Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous(IV) Therapy and Vein Access as of 2022)
4.3 Date of Key Players Enter into Intravenous(IV) Therapy and Vein Access Market
4.4 Global Top Players Intravenous(IV) Therapy and Vein Access Headquarters and Area Served
4.5 Key Players Intravenous(IV) Therapy and Vein Access Product Solution and Service
4.6 Competitive Status
4.6.1 Intravenous(IV) Therapy and Vein Access Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 B. Braun
5.1.1 B. Braun Profile
5.1.2 B. Braun Main Business
5.1.3 B. Braun Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.1.4 B. Braun Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.1.5 B. Braun Recent Developments
5.2 Baxter International
5.2.1 Baxter International Profile
5.2.2 Baxter International Main Business
5.2.3 Baxter International Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.2.4 Baxter International Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.2.5 Baxter International Recent Developments
5.3 Becton Dickinson
5.3.1 Becton Dickinson Profile
5.3.2 Becton Dickinson Main Business
5.3.3 Becton Dickinson Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.3.4 Becton Dickinson Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.3.5 C. R. Bard Recent Developments
5.4 C. R. Bard
5.4.1 C. R. Bard Profile
5.4.2 C. R. Bard Main Business
5.4.3 C. R. Bard Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.4.4 C. R. Bard Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.4.5 C. R. Bard Recent Developments
5.5 Fresenius Kabi
5.5.1 Fresenius Kabi Profile
5.5.2 Fresenius Kabi Main Business
5.5.3 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.5.4 Fresenius Kabi Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.5.5 Fresenius Kabi Recent Developments
5.6 Hospira(ICU Medical)
5.6.1 Hospira(ICU Medical) Profile
5.6.2 Hospira(ICU Medical) Main Business
5.6.3 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.6.4 Hospira(ICU Medical) Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.6.5 Hospira(ICU Medical) Recent Developments
5.7 Medtronic
5.7.1 Medtronic Profile
5.7.2 Medtronic Main Business
5.7.3 Medtronic Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.7.4 Medtronic Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.7.5 Medtronic Recent Developments
5.8 Smiths Group
5.8.1 Smiths Group Profile
5.8.2 Smiths Group Main Business
5.8.3 Smiths Group Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.8.4 Smiths Group Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.8.5 Smiths Group Recent Developments
5.9 Teleflex
5.9.1 Teleflex Profile
5.9.2 Teleflex Main Business
5.9.3 Teleflex Intravenous(IV) Therapy and Vein Access Products, Services and Solutions
5.9.4 Teleflex Intravenous(IV) Therapy and Vein Access Revenue (US$ Million) & (2018-2023)
5.9.5 Teleflex Recent Developments
6 North America
6.1 North America Intravenous(IV) Therapy and Vein Access Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Intravenous(IV) Therapy and Vein Access Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Intravenous(IV) Therapy and Vein Access Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Intravenous(IV) Therapy and Vein Access Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Intravenous(IV) Therapy and Vein Access Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Intravenous(IV) Therapy and Vein Access Market Dynamics
11.1 Intravenous(IV) Therapy and Vein Access Industry Trends
11.2 Intravenous(IV) Therapy and Vein Access Market Drivers
11.3 Intravenous(IV) Therapy and Vein Access Market Challenges
11.4 Intravenous(IV) Therapy and Vein Access Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List